Deleterious genetic influence of CX3CR1 genotypes on HIV-1 disease progression

被引:27
|
作者
Faure, S
Meyer, L
Genin, E
Pellet, P
Debré, P
Théodorou, I
Combadière, C
机构
[1] Hop La Pitie Salpetriere, INSERM U543, Paris, France
[2] INSERM, U569, Serv Epidemiol, Le Kremlin Bicetre, France
[3] Hop Bicetre, Fac Med, INSERM, U535, Le Kremlin Bicetre, France
关键词
HIV; chemokine; CX3CR1; polymorphism;
D O I
10.1097/00126334-200303010-00014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously reported that patients homozygous for a specific mutation (M280) in the chemokine receptor CX3CR1 progressed to AIDS more rapidly than those with other genotypes. This deleterious effect would predict that a cohort of prevalent patients would be depleted in M280 carriers, because these patients would have disappeared before recruitment. This hypothesis is confirmed ill this new Study based on the French SEROCO cohort showing that patients homozygous for the M280 allele were rare among the seroprevalent group. These results may explain the conflicting results published on the impact of CX3CR1 polymorphism in seroconverters.
引用
收藏
页码:335 / 337
页数:3
相关论文
共 50 条
  • [21] CX3CR1 polymorphisms in multiple sclerosis
    Coralie, Chanvillard
    Bhairavi, Swaminathan
    Iraide, Alloza
    Koen, Vandenbroeck
    Carmen, Infante-Duarte
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 9 - 9
  • [22] Role of chemokine CX3CL1 in progression of multiple myeloma via CX3CR1 in bone microenvironments
    Wada, Akinori
    Ito, Aya
    Iitsuka, Hirofumi
    Tsuneyama, Koichi
    Miyazono, Takayoshi
    Murakami, Jun
    Shibahara, Naotoshi
    Sakurai, Hiroaki
    Saiki, Ikuo
    Nakayama, Takashi
    Yoshie, Osamu
    Koizumi, Keiichi
    Sugiyama, Toshiro
    ONCOLOGY REPORTS, 2015, 33 (06) : 2935 - 2939
  • [23] CX3CR1 as a target for airways inflammation
    Doggrell, Sheila A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (09) : 1139 - 1142
  • [24] The control of microglial neurotoxicity by CX3CR1
    Cardona, AE
    Dutta, R
    Huang, D
    Kostenko, V
    Sasse, M
    Kidd, G
    Lee, J
    Cook, DN
    Jung, S
    Lira, SA
    Pioro, E
    Littman, DR
    Ransohoff, RM
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 : 20 - 20
  • [25] The role of CX3CR1 in aminoglycoside ototoxicity
    Sato, E.
    Ransohoff, R. M.
    Hirose, K.
    8TH INTERNATIONAL CONGRESS OF NEUROIMMUNOLOGY, 2006, : 333 - 336
  • [26] Influence of aspirin on the CX3CL1/CX3CR1 signaling pathway in acute pulmonary embolism
    Zhang, Zhirong
    Yang, Weiji
    Ying, Rongbiao
    Shi, Ying
    Jiang, Huifang
    Cai, Danli
    Kuang, Jing
    Yang, Ruhui
    Wang, Lingcong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 39 (06) : 1580 - 1588
  • [27] Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
    Stavros Apostolakis
    Demetrios Spandidos
    Acta Pharmacologica Sinica, 2013, 34 : 1251 - 1256
  • [28] Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
    Apostolakis, Stavros
    Spandidos, Demetrios
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (10) : 1251 - 1256
  • [29] Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
    Limatola, Cristina
    Ransohoff, Richard M.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [30] The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
    Pawelec, Paulina
    Ziemka-Nalecz, Malgorzata
    Sypecka, Joanna
    Zalewska, Teresa
    CELLS, 2020, 9 (10) : 1 - 17